204 related articles for article (PubMed ID: 29552198)
1. MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia.
Bi L; Sun L; Jin Z; Zhang S; Shen Z
Oncol Lett; 2018 Apr; 15(4):5611-5619. PubMed ID: 29552198
[TBL] [Abstract][Full Text] [Related]
2. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
5. [MicroRNA-10a expression in FAB different subtype of acute myeloid leukemia and its relationship with drug resistance].
Zhi YJ; Zhi F; Wang R; Xue L; Gu WY; Wang B; Dong WM; Li HQ; Ling Y; Qiu GQ; Wang ZL; Cao XS; Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):29-33. PubMed ID: 25687041
[TBL] [Abstract][Full Text] [Related]
6. miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death.
Bryant A; Palma CA; Jayaswal V; Yang YW; Lutherborrow M; Ma DD
Mol Cancer; 2012 Feb; 11():8. PubMed ID: 22348345
[TBL] [Abstract][Full Text] [Related]
7. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
8. The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.
Zou Q; Tan S; Yang Z; Wang J; Xian J; Zhang S; Jin H; Yang L; Wang L; Zhang L
Oncotarget; 2016 Nov; 7(44):71477-71490. PubMed ID: 27669739
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells.
Yuan Z; Wang W
Hematology; 2020 Dec; 25(1):160-164. PubMed ID: 32319862
[No Abstract] [Full Text] [Related]
10. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
11. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
Weng H; Lal K; Yang FF; Chen J
Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide miRNA profiling and pivotal roles of miRs 125a-5p and 17-92 cluster in human neutrophil maturation and differentiation of acute myeloid leukemia cells.
Dakir el-H; Mollinedo F
Oncotarget; 2019 Sep; 10(51):5313-5331. PubMed ID: 31523391
[TBL] [Abstract][Full Text] [Related]
13. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
[TBL] [Abstract][Full Text] [Related]
14. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.
Zheng YS; Zhang H; Zhang XJ; Feng DD; Luo XQ; Zeng CW; Lin KY; Zhou H; Qu LH; Zhang P; Chen YQ
Oncogene; 2012 Jan; 31(1):80-92. PubMed ID: 21643017
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
Hartmann JU; Bräuer-Hartmann D; Kardosova M; Wurm AA; Wilke F; Schödel C; Gerloff D; Katzerke C; Krakowsky R; Namasu CY; Bill M; Schwind S; Müller-Tidow C; Niederwieser D; Alberich-Jorda M; Behre G
Cell Death Dis; 2018 Jul; 9(8):814. PubMed ID: 30050105
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
17. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
18. Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
Barrera-Ramirez J; Lavoie JR; Maganti HB; Stanford WL; Ito C; Sabloff M; Brand M; Rosu-Myles M; Le Y; Allan DS
Stem Cell Rev Rep; 2017 Dec; 13(6):817-825. PubMed ID: 28918518
[TBL] [Abstract][Full Text] [Related]
19.
Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J
Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526
[No Abstract] [Full Text] [Related]
20. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
Morikawa J; Li H; Kim S; Nishi K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T
Int J Oncol; 2003 Sep; 23(3):617-25. PubMed ID: 12888896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
